Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1993 Mar 15;148(6):921–924.

Technology assessment and cost-effectiveness analysis: misguided guidelines?

C D Naylor 1, J I Williams 1, A Basinski 1, V Goel 1
PMCID: PMC1490754  PMID: 8448706

Full text

PDF
921

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battista R. N. Health care technology assessment: linking science and policy-making. CMAJ. 1992 Feb 15;146(4):461–462. [PMC free article] [PubMed] [Google Scholar]
  2. Birch S., Donaldson C. Applications of cost-benefit analysis to health care. Departures from welfare economic theory. J Health Econ. 1987 Sep;6(3):211–225. doi: 10.1016/0167-6296(87)90009-9. [DOI] [PubMed] [Google Scholar]
  3. Detsky A. S., Naylor C. D., O'Rourke K., McGeer A. J., L'Abbé K. A. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol. 1992 Mar;45(3):255–265. doi: 10.1016/0895-4356(92)90085-2. [DOI] [PubMed] [Google Scholar]
  4. Drummond M. F., Stoddart G. L. Economic analysis and clinical trials. Control Clin Trials. 1984 Jun;5(2):115–128. doi: 10.1016/0197-2456(84)90118-1. [DOI] [PubMed] [Google Scholar]
  5. Garber A. M. Where to draw the line against cholesterol. Ann Intern Med. 1989 Oct 15;111(8):625–627. doi: 10.7326/0003-4819-111-8-625. [DOI] [PubMed] [Google Scholar]
  6. Goel V., Naylor C. D. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction. Can J Cardiol. 1992 Jan-Feb;8(1):31–38. [PubMed] [Google Scholar]
  7. La Puma J., Lawlor E. F. Quality-adjusted life-years. Ethical implications for physicians and policymakers. JAMA. 1990 Jun 6;263(21):2917–2921. doi: 10.1001/jama.263.21.2917. [DOI] [PubMed] [Google Scholar]
  8. Laupacis A., Feeny D., Detsky A. S., Tugwell P. X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992 Feb 15;146(4):473–481. [PMC free article] [PubMed] [Google Scholar]
  9. Sackett D. L. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1989 Feb;95(2 Suppl):2S–4S. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES